Discovery of Novel Biomarkers for Alzheimer’s Disease from Blood

الملخص EN

Blood-based biomarkers for Alzheimer’s disease would be very valuable because blood is a more accessible biofluid and is suitable for repeated sampling.

However, currently there are no robust and reliable blood-based biomarkers for practical diagnosis.

In this study we used a knowledge-based protein feature pool and two novel support vector machine embedded feature selection methods to find panels consisting of two and three biomarkers.

We validated these biomarker sets using another serum cohort and an RNA profile cohort from the brain.

Our panels included the proteins ECH1, NHLRC2, HOXB7, FN1, ERBB2, and SLC6A13 and demonstrated promising sensitivity (>87%), specificity (>91%), and accuracy (>89%).